Reduced QSOX1 enhances radioresistance in nasopharyngeal carcinoma

Lei Zhou, Hongmin Chen, Song Qu, Ling Li, Wei Zhao, Zhongguo Liang, Binbin Yu, Kai-Hua Chen, Qiteng Lu, Guoxiang Lin,

Oncotarget · 2017 · 13 citations · 25 references

DOIFull text

Open access

Concepts

Abstract

// Lei Zhou 1, * , Hong-Min Chen 1, * , Song Qu 1, 2, 3 , Ling Li 1, 2, 3 , Wei Zhao 1 , Zhong-Guo Liang 1 , Bin-Bin Yu 1 , Kai-Hua Chen 1 , Qi-Teng Lu 1 , Guo-Xiang Lin 1 and Xiao-Dong Zhu 1, 2, 3, 4 1 Department of Radiation Oncology, Affiliated Tumor Hospital of Guangxi Medical University and Cancer Institute of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, P.R. China 2 Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Guangxi Medical University, Nanning, Guangxi, P.R. China 3 Key Laboratory of High-Incidence-Tumor Prevention and Treatment, Guangxi Medical University, Ministry of Education, Nanning, Guangxi, P.R. China 4 Department of Oncology, Affiliated Wuming Hospital of Guangxi Medical University, Nanning, Guangxi, P.R. China * These authors contributed equally to this work Correspondence to: Xiao-Dong Zhu, email: zhuxdonggxmu@126.com Keywords: QSOX1; nasopharyngeal carcinoma; radiosensitivity; CNE-2; radiotherapy Received: August 18, 2017      Accepted: November 16, 2017      Published: December 14, 2017 ABSTRACT Radioresistance is a major cause leads to treatment failure in nasopharyngeal carcinoma (NPC). In our previous study, we identified that QSOX1 is a differentially expressed protein in NPC cell lines with variable radiosensitivities. The present study aimed to investigate the biological behavior of QSOX1 in nasopharyngeal carcinoma (NPC) and its effect on radiosensitivity. The levels of QSOX1 detected by enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry (IHC) in radioresistant NPC patient sera and tissue samples were markedly lower than those in radiosensitive samples. Small hairpin RNAs (shRNAs) were employed to knock down endogenous QSOX1 expression in CNE-2 cells, and then, radiosensitivity, apoptosis, migration and invasion were assessed using colony formation, Cell Counting Kit-8 (CCK-8), flow cytometry, and transwell assays, respectively. Tumor growth and radioresistance were also evaluated using a xenograft model in nude mice. The shRNA-mediated knockdown of QSOX1 significantly increased cell survival under irradiation (IR) and weakened radiosensitivity, which was likely due to a reduction in the cell apoptosis rate after IR. Moreover, QSOX1 silencing led to the suppression of cellular migration and invasion. Similar results were obtained with the xenograft mouse model. Thus, targeting QSOX1 will provide a new avenue for increasing the sensitivity of NPC to radiotherapy.

References

25